| Literature DB >> 29028803 |
Cynthia J Price1, Elaine Adams Thompson2, Sunny Chieh Cheng3.
Abstract
The Scale of Body Connection (SBC) was created to address the need for a self-report measure to examine body awareness and bodily dissociation in mind-body research. Developed in the U.S.A., it has been translated into many languages and tested for validity of scale translation. The burgeoning of mind-body research and the widespread use of the SBC scale underscored the need for critical assessment of the instrument's measurement properties. Thus, a broader evaluation of the SBC was designed using large samples from eight international, cross-sectional studies drawn from community (i.e., non-clinical) populations. Specifically, we assessed scale distribution properties and internal consistency reliabity, and using confirmatory factory analysis we evaluated scale contruct validity and compared male/female measurement models. The results indicated acceptable reliability for both the body awareness and bodily dissociation scales, and a good fit between the proposed theoretic model and the data, providing evidence of construct validity across all samples. Mean differences in body awareness were observed for males vs. females in most samples, with females generally showing higher body awareness compared to males. Multi-group structural equation modeling demonstrated a stable latent factor structure and factor loadings, indicating equivalent measurement models for males and females. In summary, this multi-sample study demonstrated SBC construct validity that supports its use in clinical research as a brief, readily translated, easy to administer measure of body awareness and bodily dissociation.Entities:
Mesh:
Year: 2017 PMID: 29028803 PMCID: PMC5640211 DOI: 10.1371/journal.pone.0184757
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Description of sample datasets.
| Study | Country (translated language) | Type of Sample | Recruitment Process | Data Collection Mode | Sample Size | Age range | Female | Male |
|---|---|---|---|---|---|---|---|---|
| 1 | Italy (Italian) | Community | Covenience | Online | 576 | 17–72 (27.0) | 396 (68.8%) | 180 (31.3%) |
| 2 | France (French) | Community | Convenience | Online | 198 | 19–70 (39.0) | 181(31.4%) | 17 (8.6%) |
| 3 | Netherlands (Dutch) [ | Undergraduates | Convenience | In-Person | 434 | 16–38 (20.0) | 321 (75.57%) | 103 (24.29%) |
| 4 | Portugual (Portuguese) [ | Community | Convenience | Online | 909 | 18–72 (31.0) | 445 (49.0%) | 464 (51.0%) |
| 5 | USA (a) [ | Undergraduates | Convenience | In-Person | 291 | 16–46 (20.0) | 162 (57.7%) | 119 (42.3%) |
| 6 | USA (b) | Somatic Therapists | Purposive | Online | 290 | 18–79 (48.5) | 290 (100%) | ––– |
| 7 | USA (c) [ | Lesbian Women | Convenience | Online | 328 | 21–79 (49.0) | 240 (78.7%) | 65 (21.3%) |
| 8 | Israel (Hebrew) | Undergraduates | Convenience | In-Person | 608 | 18–54 (28.0) | 377 (62.0%) | 231 (38.0%) |
*USA (b) sample included only females. Missing values indicated by dashes (–).
SBC scale means and distributional properties and internal consistency reliability.
| Scale | Country | Mean ± SD | Skew | Kurtosis | Reliability Cronbach alpha |
|---|---|---|---|---|---|
| SBC-BA | Italy | 2.74 ± .57 | -.42 | .06 | .82 |
| France | 2.56 ± .63 | -.48 | .27 | .83 | |
| Netherlands | 2.51 ± .38 | .01 | .04 | .72 | |
| Portugual | 2.29 ± .75 | -.24 | -.22 | .86 | |
| USA (a) | 2.36 ± .66 | -.28 | .08 | .86 | |
| USA (b) | 2.23 ± .66 | -.30 | .35 | .84 | |
| USA (c) | – | – | – | – | |
| Israel | 2.58 ± .66 | -.31 | -.19 | .86 | |
| SBC-BD | Italy | 1.37 ± .52 | .34 | -.11 | .64 |
| France | 0.96 ± .63 | 1.36 | 2.98 | .75 | |
| Netherlands | 1.41 ± .43 | .01 | .14 | .63 | |
| Portugual | 0.95 ± .59 | 1.01 | 1.79 | .71 | |
| USA (a) | 1.07 ± .61 | .67 | .60 | .79 | |
| USA (b) | 0.94 ± .61 | 1.16 | 1.52 | .81 | |
| USA (c) | 1.30 ± .73 | .87 | .91 | .76 | |
| Israel | – | – | – | – |
Only the SBC-BD was administered in the USA (c) study; only the SBC-BA was administered in the Israeli study. Missing values indicated by dashes (–).
CFA goodness of fit indices and SBC-BA/SBC-BD factor correlations by study sample.
| SBC Scale | Country | CFI | TLI | RMSEA | SBC-BA/SBC-BD Factor Correlation |
|---|---|---|---|---|---|
| Body Awareness | Italy | .95 | .94 | .05 | -.42 |
| France | .90 | .88 | .08 | -.37 | |
| Netherlands | .92 | .90 | .05 | -.30 | |
| Portugual | .97 | .95 | .05 | .24 | |
| USA (a) | .97 | .96 | .04 | .03 | |
| USA (b) | .95 | .93 | .06 | -.23 | |
| USA (c) | – | – | – | – | |
| Israel | .96 | .94 | .06 | – | |
| Bodily Dissociation | Italy | .96 | .93 | .05 | |
| France | .91 | .86 | .10 | ||
| Netherlands | .94 | .91 | .05 | ||
| Portugual | .97 | .94 | .06 | ||
| USA (a) | .93 | .89 | .08 | ||
| USA (b) | .99 | .99 | .02 | ||
| USA (c) | .95 | .92 | .08 | ||
| Israel | – | – | – |
Only the SBC-BD was administered in the USA (c) study; only The SBC-BA was administered in the Israeli study. Missing values indicated by dashes (–).
Confirmatory factor analysis: Item loadings for SBC scales.
| SBC Scale Item Number & Description | Country | |||||||
|---|---|---|---|---|---|---|---|---|
| Italy | France | Netherlands | Portugual | USA (a) | USA(b) | USA (c) | Israel | |
| 1. Aware of tension | .46 (1.00) | .53 (1.00) | .48 (1.00) | .56 (1.00) | .50 (1.00) | .57 (1.00) | – | .59 (1.00) |
| 3. Breathing shallow | .43 (1.45) | .33 (.99) | .20 (.57) | .46 (.96) | .42 (1.09) | .23 (.49) | – | .49 (1.08) |
| 4. Notice response to touch | .39 (1.02) | .35 (.72) | .33 (.85) | .49 (.82) | .50 (1.01) | .33 (.68) | – | .52 (.86) |
| 6. Notice body change when angry | .53 (1.62) | .41 (1.06) | .28 (.79) | .57 (1.30) | .59 (1.37) | .62 (1.31) | – | .63 (1.21) |
| 8. Aware during sexual activity | .30 (.79) | .48 (1.20) | .21 (.52) | .48 (.86) | .44 (.97) | .39 (.79) | – | .37 (.60) |
| 9. Can feel breath travel | .46 (1.63) | .51 (1.57) | .43 (1.34) | .51 (1.13) | .57 (1.43) | .39 (.90) | – | .53 (1.11) |
| 12. Take cues from body | .62 (2.03) | .66 (1.66) | .52 (1.30) | .57 (1.17) | .65 (1.51) | .65 (1.25) | – | .52 (1.03) |
| 13. Think about cause of discomfort | .52 (1.52) | .66 (1.55) | .52 (1.41) | .56 (1.10) | .48 (1.13) | .58 (1.12) | – | .69 (1.39) |
| 14. Listen to body about emotional state | .72 (2.24) | .78 (1.87) | .54 (1.35) | .64 (1.34) | .69 (1.62) | .74 (1.52) | – | .71 (1.53) |
| 15. Notice stress in body | .58 (1.54) | .60 (1.27) | .34 (.91) | .68 (1.29) | .47 (.98) | .80 (1.53) | – | .67 (1.41) |
| 17. Note where tension is in body | .62 (2.12) | .64 (1.73) | .59 (1.86) | .64 (1.24) | .65 (1.51) | .68 (1.34) | – | .65 (1.35) |
| 18. Notice peaceful experience | .55 (1.59) | .61 (1.66) | .43 (1.03) | .64 (1.28) | .57 (1.30) | .61 (1.27) | – | .27 (.46) |
| Italy | France | Netherlands | Portugual | USA (a) | USA(b) | USA (c) | Israel | |
| 2. Difficult to identify emotions | .69 (1.00) | .71 (1.00) | .41 (1.00) | .27 (1.00) | .65 (1.00) | .44 (1.00) | .65 (1.00) | – |
| 5. Body feels frozen, numb | .18 (.36) | .19 (.33) | .28 (.73) | .28 (1.33) | .29 (.49) | .68 (1.73) | .57 (.95) | – |
| 7. Looking at body from outside | .13 (.23) | .37 (.59) | .11 (.28) | .75 (2.84) | .44 (.70) | .54 (.82) | .42 (.58) | – |
| 10. Feel separated from body | .30 (.46) | .57 (.76) | .15 (.41) | .82 (2.76) | .39 (.58) | .78 (1.54) | .50 (.67) | – |
| 11. Hard to express emotions | .59 (.99) | .78 (1.21) | .76 (1.93) | .28 (1.24) | .75 (1.34) | .49 (1.02) | .65 (1.07) | – |
| 16. Distract self from discomfort | .10 (.16) | .21 (.30) | .35 (.79) | .14 (.57) | .35 (.64) | .38 (.82) | .29 (.43) | – |
| 19. Separated during sexual activity | .29 (.44) | .51 (.79) | .22 (.57) | .74 (3.01) | .43 (.65) | .68 (1.45) | N/A | – |
| 20. Difficult to pay attention to emotions | .74 (1.13) | .75 (1.05) | .69 (1.90) | .34 (1.34) | .70 (1.18) | .50 (1.13) | .76 (1.11) | – |
Reported are standardized coefficients with unstandardized coefficients in parentheses. Only the SBC-BD was administered in the USA (c) study; only the SBC-BA was administered in Israeli study. Missing values indicated by dashes (–).
F Tests for sex differences for SBC-BA and SBC-BD scales.
| Country | Sex | SBC-BA | F test | SBC-BD | F test |
|---|---|---|---|---|---|
| Mean (SD) | p value | Mean (SD) | p value | ||
| Italy | Female | 2.83 (.53) | 38.15, | 1.37 (.52) | 0.01, |
| Male | 2.52 (.60) | 1.37 (.50) | |||
| France | Female | 2.56 (.61) | 0.11, | .97 (.64) | 1.33, |
| Male | 2.61 (.84) | .79 (.44) | |||
| Netherlands | Female | 2.47 (.37) | 1.28, | 1.43 (.43) | 3.02, |
| Male | 2.64 (.41) | 1.34 (.41) | |||
| Portugal | Female | 2.49 (.69) | 68.38, | 1.01 (.62) | 9.00, |
| Male | 2.09 (.74) | .89 (.54) | |||
| USA (a) | Female | 2.40 (.62) | 1.73, | 1.11 (.63) | 1.73, |
| Male | 2.30 (.72) | 1.01 (.59) | |||
| USA (c) | Female | – | – | 1.28 (.71) | 0.41, p = .52 |
| Male | – | 1.34 (.83) | |||
| Israel | Female | 2.69 (.62) | 29.23, | – | – |
| Male | 2.40 (.69) | – |
** p < .01;
*** p < .001.
Only the SBC-BD was administered in the USA (c) study; only the SBC-BA was administered in the Israeli study. Missing values indicated by dashes (–). USA (b) sample did not include males, and thus not included in these analysis.
Tests for model equivalence by sex: Multi-group CFA across diverse community-based samples.
| Model | Country N (males/females) | ML χ2 | df | CFI | TLI | RMSEA | SRMR | χ2diff
| dfdiff
| P |
|---|---|---|---|---|---|---|---|---|---|---|
| Italy (180/396) | 762.54 | 333 | .82 | .79 | .07 | .08 | – | – | – | |
| Netherlands (321/103) | 524.24 | 334 | .83 | .81 | .05 | .07 | – | – | – | |
| Portugal (464/445) | 1035.71 | 330 | .86 | .84 | .07 | .08 | – | – | – | |
| USA (a) (119/162) | 513.32 | 332 | .88 | .86 | .06 | .09 | – | – | – | |
| USA (c) (59/233) | 34.71 | 26 | .98 | .96 | .05 | .04 | – | – | – | |
| Israel (231/377) | 307.22 | 100 | .92 | .90 | .08 | .06 | – | – | – | |
| Italy | 786.07 | 351 | .81 | .80 | .07 | .08 | 23.53 | 18 | .17 | |
| Netherlands | 546.91 | 352 | .83 | .81 | .05 | .08 | 21.96 | 18 | .23 | |
| Portugal | 1021.47 | 347 | .87 | .85 | .07 | .08 | 14.24 | 17 | .65 | |
| USA (a) | 530.69 | 350 | .88 | .87 | .06 | .09 | 17.37 | 18 | .50 | |
| USA (c) | 42.23 | 32 | .97 | .96 | .05 | .06 | 7.52 | 6 | .28 | |
| Israel | 317.67 | 111 | .92 | .91 | .08 | .06 | 10.46 | 11 | .49 | |
| Italy | 786.07 | 352 | .82 | .80 | .07 | .08 | 0.001 | 1 | .97 | |
| Netherlands | NA | – | – | – | – | – | – | – | – | |
| Portugal | 1023.59 | 351 | .87 | .86 | .07 | .08 | 2.12 | 4 | .71 | |
| USA (a) | 531.02 | 352 | .88 | .87 | .06 | .09 | 0.33 | 2 | .85 | |
| USA (c) | 42.36 | 33 | .97 | .97 | .04 | .06 | 0.14 | 1 | .71 | |
| Israel | 321.78 | 114 | .92 | .91 | .08 | .06 | 4.11 | 3 | .25 | |
| Italy | 793.76 | 355 | .81 | .80 | .07 | .09 | 7.69 | 3 | .05 | |
| Netherlands | 551.82 | 355 | .82 | .81 | .05 | .08 | 5.63 | 3 | .13 | |
| Portugal | 1051.24 | 354 | .86 | .85 | .07 | .09 | 27.65 | 3 | < .002 | |
| USA (a) | 541.05 | 355 | .88 | .87 | .06 | .10 | 10.03 | 3 | .02 | |
| USA (c) | NA | – | – | – | – | – | – | – | – | |
| Israel | NA | – | – | – | – | – | – | – | – |
a The Netherlands male and female samples had no common residual variances, thus not necessary to test (NA).
b Only one of the two SBC scales were used in two studies; the analysis for structural covariance was not applicable (NA). That is, only the SBC-BD scale was administered in the USA (c) study; only the SBC-BA scale was administered in the Israeli study. The French and USA (b) samples were not included in these analyses because the datasets included either no males or an insufficient number of males for analyses.
c χ2diff = differences in chi square values between two models compared.
d dfdiff = difference in degrees of freedom between two models compared.